10-K/A Filing

TRUCEPT, INC. CIK: 947011 FY 2011

Filing Information

Form Type	10-K/A
Accession Number	`0001062993-12-003350`
Period End Date	20111231
Filing Date	20120830
Fiscal Year	2011
Fiscal Period	FY
XBRL Instance	sttk-20111231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 34 Cash Flow Statement 52 Stockholders Equity 10

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, Par Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$132.49K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$781.72K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$234.55K	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.63M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.69M	USD	Point-in-time
Due from related parties	`OtherReceivablesNetCurrent`	$2.74M	USD	Point-in-time
Due from related parties	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Common Stock, Par Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and deposits	`PrepaidExpenseCurrent`	$52.15K	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Prepaid expenses and deposits	`PrepaidExpenseCurrent`	$69.09K	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	24.31M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	49.21M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.55M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.54M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	49.21M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	24.31M	shares	Point-in-time
Equipment, net of accumulated depreciation	`MachineryAndEquipmentGross`	$47.50K	USD	Point-in-time
Equipment, net of accumulated depreciation	`MachineryAndEquipmentGross`	$55.01K	USD	Point-in-time
Prepaid workers compensation	`PrepaidExpenseOtherNoncurrent`	$2.35M	USD	Point-in-time
Prepaid workers compensation	`PrepaidExpenseOtherNoncurrent`	$3.44M	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Goodwill	`Goodwill`	$476.36K	USD	Point-in-time
Total Assets	`Assets`	$8.52M	USD	Point-in-time
Total Assets	`Assets`	$4.93M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.36M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.27M	USD	Point-in-time
Accrued payroll taxes	`AccruedPayrollTaxesCurrent`	$1.41M	USD	Point-in-time
Accrued payroll taxes	`AccruedPayrollTaxesCurrent`	$11.96M	USD	Point-in-time
Accrued workers compensation	`WorkersCompensationLiabilityCurrent`	$1.06M	USD	Point-in-time
Accrued workers compensation	`WorkersCompensationLiabilityCurrent`	-	USD	Point-in-time
Payable to related parties	`AccountsPayableRelatedPartiesCurrent`	$388.42K	USD	Point-in-time
Payable to related parties	`AccountsPayableRelatedPartiesCurrent`	$609.02K	USD	Point-in-time
Note payable to related party	`NotesPayableRelatedPartiesClassifiedCurrent`	-	USD	Point-in-time
Note payable to related party	`NotesPayableRelatedPartiesClassifiedCurrent`	$500.00K	USD	Point-in-time
Total current liability	`LiabilitiesCurrent`	$15.39M	USD	Point-in-time
Total current liability	`LiabilitiesCurrent`	$4.16M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$35.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$15.43M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.16M	USD	Point-in-time
Preferred stock: $0.001 par value, 5,000,000 shares authorized, zero shares of Class A preferred issued and outstanding at December 31, 2011 and 2010	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock: $0.001 par value, 5,000,000 shares authorized, zero shares of Class A preferred issued and outstanding at December 31, 2011 and 2010	`PreferredStockValue`	-	USD	Point-in-time
Common stock: $0.001 par value, 500,000,000 shares authorized, 49,212,123 and 24,314,124 issued and outstanding at December 31, 2011 and 2010, respectively	`CommonStockValue`	$24.32K	USD	Point-in-time
Common stock: $0.001 par value, 500,000,000 shares authorized, 49,212,123 and 24,314,124 issued and outstanding at December 31, 2011 and 2010, respectively	`CommonStockValue`	$49.21K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$7.27M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$6.85M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-14.23M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-6.10M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-6.90M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$774.99K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-35.20K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$8.52M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$4.93M	USD	Point-in-time

Income Statement 34 line items

Line Item	Tag	Value	Unit	Period
Revenue (gross billings of $97,394 and $68.556 million, less worksite employee payroll cost of $75.646 million and $51.33 million respectively)	`Revenues`	$17.23M	USD	Annual
Revenue (gross billings of $97,394 and $68.556 million, less worksite employee payroll cost of $75.646 million and $51.33 million respectively)	`Revenues`	$21.75M	USD	Annual
Gross billings	`GrossBillings`	$68.56M	USD	Annual
Gross billings	`GrossBillings`	$97.39M	USD	Annual
Cost of revenue and service delivery	`CostOfRevenue`	$13.32M	USD	Annual
Employee payroll costs	`EmployeePayrollCosts`	$51.33M	USD	Annual
Cost of revenue and service delivery	`CostOfRevenue`	$20.81M	USD	Annual
Employee payroll costs	`EmployeePayrollCosts`	$75.65M	USD	Annual
Gross profit	`GrossProfit`	$943.01K	USD	Annual
Gross profit	`GrossProfit`	$3.90M	USD	Annual
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$6.95M	USD	Annual
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.16M	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$-6.01M	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$743.00K	USD	Annual
Interest	`InterestExpense`	$192.30K	USD	Annual
Interest	`InterestExpense`	$21.91K	USD	Annual
Tax penalties	`TaxPenalties`	$1.74M	USD	Annual
Tax penalties	`TaxPenalties`	-	USD	Annual
Legal Settlement	`LegalFees`	$180.00K	USD	Annual
Legal Settlement	`LegalFees`	-	USD	Annual
Other income/(expense)	`OtherNonoperatingIncomeExpense`	-	USD	Annual
Other income/(expense)	`OtherNonoperatingIncomeExpense`	$3.75K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-2.11M	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-21.91K	USD	Annual
Net income (loss) from continuing operations	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-8.12M	USD	Annual
Net income (loss) from continuing operations	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$721.09K	USD	Annual
Net income from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$134.10K	USD	Annual
Net income from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$855.19K	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-8.12M	USD	Annual
Earnings per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$0.01	USD	Annual
Earnings per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.21	USD	Annual
Weighted average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	64.51M	shares	Annual
Weighted average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.03M	shares	Annual

Cash Flow Statement 52 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-8.12M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$855.19K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$20.21K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$22.36K	USD	Annual
Share based compensation expense	`ShareBasedCompensation`	$-45.00K	USD	Annual
Share based compensation expense	`ShareBasedCompensation`	$443.98K	USD	Annual
Miscellaneous assets	`MiscellaneousAssets`	$-11.36K	USD	Annual
Miscellaneous assets	`MiscellaneousAssets`	-	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$150.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$86.60K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.46M	USD	Annual
Due from related party	`IncreaseDecreaseInDueFromRelatedParties`	-	USD	Annual
Due from related party	`IncreaseDecreaseInDueFromRelatedParties`	$2.74M	USD	Annual
Proceeds from related party	`ProceedsFromRelatedPartyDebt`	$388.42K	USD	Annual
Proceeds from related party	`ProceedsFromRelatedPartyDebt`	$220.61K	USD	Annual
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidExpense`	$-16.94K	USD	Annual
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidExpense`	$785.33K	USD	Annual
Prepaid worker compensation expense	`IncreaseDecreaseInOtherNoncurrentAssets`	-	USD	Annual
Prepaid worker compensation expense	`IncreaseDecreaseInOtherNoncurrentAssets`	$1.09M	USD	Annual
Payroll taxes payable	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$10.44M	USD	Annual
Payroll taxes payable	`IncreaseDecreaseInEmployeeRelatedLiabilities`	-	USD	Annual
Accrued workers compensation	`IncreaseDecreaseInWorkersCompensationLiabilities`	-	USD	Annual
Accrued workers compensation	`IncreaseDecreaseInWorkersCompensationLiabilities`	$1.06M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.85M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-950.36K	USD	Annual
Net cash provided (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-656.51K	USD	Annual
Net cash provided (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$825.06K	USD	Annual
Purchase of equipment	`PaymentsToAcquireMachineryAndEquipment`	$27.72K	USD	Annual
Purchase of equipment	`PaymentsToAcquireMachineryAndEquipment`	$38.53K	USD	Annual
Cash paid in purchase of Solvis Medical Group assets	`PaymentsForPurchaseOfOtherAssets`	-	USD	Annual
Cash paid in purchase of Solvis Medical Group assets	`PaymentsForPurchaseOfOtherAssets`	$-35.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$7.28K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-38.53K	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	Annual
Net increase (decrease) in cash from continuing operations	`NetCashProvidedByUsedInContinuingOperations`	$-649.23K	USD	Annual
Net increase (decrease) in cash from continuing operations	`NetCashProvidedByUsedInContinuingOperations`	$786.53K	USD	Annual
Net increase (decrease) in cash from discontinued operations	`NetCashProvidedByUsedInDiscontinuedOperations`	-	USD	Annual
Net increase (decrease) in cash from discontinued operations	`NetCashProvidedByUsedInDiscontinuedOperations`	$-239.36K	USD	Annual
Cash and cash equivalents, beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$132.49K	USD	Point-in-time
Cash and cash equivalents, beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$781.72K	USD	Point-in-time
Cash and cash equivalents, beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$234.55K	USD	Point-in-time
Cash and cash equivalents, end of the year	`CashAndCashEquivalentsAtCarryingValue`	$132.49K	USD	Point-in-time
Cash and cash equivalents, end of the year	`CashAndCashEquivalentsAtCarryingValue`	$781.72K	USD	Point-in-time
Cash and cash equivalents, end of the year	`CashAndCashEquivalentsAtCarryingValue`	$234.55K	USD	Point-in-time
Interest paid	`InterestPaid`	$21.91K	USD	Annual
Interest paid	`InterestPaid`	$192.30K	USD	Annual
Income taxes payable	`IncomeTaxesPaid`	-	USD	Annual
Income taxes payable	`IncomeTaxesPaid`	-	USD	Annual
Note payable - purchase of Solvis Medical Group assets	`NotesIssued1`	$500.00K	USD	Annual
Note payable - purchase of Solvis Medical Group assets	`NotesIssued1`	-	USD	Annual

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$-6.90M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$774.99K	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$-35.20K	USD	Point-in-time
Shares cancelled for amended Marketing Partner Agreement	`StockRepurchasedAndRetiredDuringPeriodValue`	$-45.00K	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$443.98K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-8.12M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$855.19K	USD	Annual
Ending Balance	`StockholdersEquity`	$-6.90M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$774.99K	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$-35.20K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.